Paranovus Entertainment Technology Ltd. (PAVS)
- Previous Close
1.0900 - Open
1.1000 - Bid --
- Ask --
- Day's Range
1.0000 - 1.1600 - 52 Week Range
0.9900 - 5.0300 - Volume
11,726 - Avg. Volume
5,668 - Market Cap (intraday)
7.337M - Beta (5Y Monthly) 0.05
- PE Ratio (TTM)
-- - EPS (TTM)
-9.5700 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Aug 7, 2020
- 1y Target Est
--
Paranovus Entertainment Technology Ltd. engages in the research, development, manufacture, and sale of nutraceutical and dietary supplement products in the People's Republic of China and internationally. The company's product category includes lucidum spore powders, cordyceps mycelia, Ejiao products, American ginseng products, other traditional Chinese herbal and animal extracts, vitamins, minerals, and amino acids. It also offers product marketing and e-commerce agency operation services under the Happy Buy platform to small and middle size businesses; and e-commerce solutions, internet information, and advertising services to the online stores or manufactures. In addition, the company provides secure transaction environment, automobile procurement, and financial services for automobile manufacturers under the Taochejun automobile sales platform. It sells its products through distributors, large-scale chain drugstores, malls, and supermarkets under the Happiness brand. The company was formerly known as Happiness Development Group Limited and changed its name to Paranovus Entertainment Technology Ltd. in March 2023. The company was founded in 2004 and is headquartered in Nanping, the People's Republic of China.
www.pavs.aiRecent News: PAVS
Performance Overview: PAVS
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PAVS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PAVS
Valuation Measures
Market Cap
7.34M
Enterprise Value
6.22M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.08
Price/Book (mrq)
0.69
Enterprise Value/Revenue
0.07
Enterprise Value/EBITDA
-0.12
Financial Highlights
Profitability and Income Statement
Profit Margin
-46.60%
Return on Assets (ttm)
-99.23%
Return on Equity (ttm)
-193.82%
Revenue (ttm)
87.57M
Net Income Avi to Common (ttm)
-59.86M
Diluted EPS (ttm)
-9.5700
Balance Sheet and Cash Flow
Total Cash (mrq)
1.04M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-27.31M